In summary, our study provides evidences stating that up‐regulation of miR‐92a can promote cervical cancer cell proliferation and suppress the immune function by targeting PTEN by activating the MAPK/ERK signaling pathway. The gene discussed is MAPK1; the disease is cervical cancer.